The technology opportunity analysis of patent based on neural network——taking biological nanomedicine as an exampleSHAN Zhi-yi, GUAN Zhi-hao, AN Xin-ying865-871
Research progress of pharmaceutical innovation in China based on CiteSpace visualization analysisFAN Yu-lu, FANG Zhong-jian, YAO Hong, DING Yong, CHEN Yu-wen, XU Yi-xin878-885
Technical requirements of quality research on peptide chemical generic drug and case studyWANG Shao-rong, ZHANG Jun-lin, BAI Yu886-892
Research progress on the anti-tumor effect of triptolide and its nano preparationsLANG Xiao-xue, XUE Jian-qiao, FU Jing, ZENG Ya-wen, CAI Meng-ru, HUANG Hua-ting, QU Chang-hai, YIN Xing-bin, NI Jian, DONG Xiao-xu893-901
The signal pathway involved in the treatment of vascular cognitive impairment in rats by butylphthalideREN An-ge-shuo, GAO Ya-ran, XU Li-li, HU Ming902-905
Inetetamab combining pyrotinib as second-line treatment of HER2-positive patients: A case reportLI Yang, PENG Wei, ZHONG Jin-cai916-920
Exploration and practice of remote supervision and inspection in drug clinical trial institutionsZHU Jun-jie, DONG Zhen, MA Xian-fu, YAN Zhao, LI Hui921-926